推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

Drug Design Development and Therapy

2023年12月最新中科院分区表数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 DRUG DES DEV TH最新评论:同3月5日投稿,也是1a-2 (2024-04-16)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中科院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


Drug Design Development and Therapy期刊基本信息Hello,您是该期刊的第122920位访客

基本信息 登录收藏
期刊名字Drug Design Development and TherapyDrug Design Development and Therapy

DRUG DES DEV THER
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
6.8
60人评分
我要评分

声誉
7.3

影响力
5.8

速度
9.2

期刊ISSN1177-8881
微信扫码收藏此期刊
2022-2023最新影响因子
(数据来源于搜索引擎)
4.8 点击查看影响因子趋势图
实时影响因子 截止2024年3月26日:4.659
2022-2023自引率0.00%点击查看自引率趋势图
五年影响因子5
h-index 48
CiteScore
CiteScoreSJRSNIPCiteScore排名
8.000.8871.213
学科分区排名百分位
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Pharmaceutical Science
Q131 / 171
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Pharmacology
Q167 / 301
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Drug Discovery
Q135 / 156

期刊简介
Drug Design, Development and Therapy is an international, peer-reviewed, open access journal that spans the spectrum of drug design, discovery and development through to clinical applications.

The journal is characterized by the rapid reporting of high-quality original research, reviews, expert opinions, commentary and clinical studies in all therapeutic areas.

Specific topics covered by the journal include:

Drug target identification and validation
Phenotypic screening and target deconvolution
Biochemical analyses of drug targets and their pathways
New methods or relevant applications in molecular/drug design and computer-aided drug discovery*
Design, synthesis, and biological evaluation of novel biologically active compounds (including diagnostics or chemical probes)
Structural or molecular biological studies elucidating molecular recognition processes
Fragment-based drug discovery
Pharmaceutical/red biotechnology
Isolation, structural characterization, (bio)synthesis, bioengineering and pharmacological evaluation of natural products**
Distribution, pharmacokinetics and metabolic transformations of drugs or biologically active compounds in drug development
Drug delivery and formulation (design and characterization of dosage forms, release mechanisms and in vivo testing)
Preclinical development studies
Translational animal models
Mechanisms of action and signalling pathways
Toxicology
Gene therapy, cell therapy and immunotherapy
Personalized medicine and pharmacogenomics
Clinical drug evaluation
Patient safety and sustained use of medicines.
期刊官方网站https://www.dovepress.com/drug-design-development-and-therapy-journal
期刊投稿网址https://www.dovepress.com/submit_step_1.php
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Drug Design Development and Therapy的语言要求,还能让Drug Design Development and Therapy编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Drug Design Development and Therapy编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问Yes
OA期刊相关信息
文章处理费:需要( USD2310; )
文章处理费豁免:查看说明

其他费用:没有
期刊主题关键词:drug design、drug safety、drug development、pharmaecuticals
相关链接:Aims & ScopeAuthor InstructionsEditorial BoardBlind peer review
通讯方式PO BOX 300-008, ALBANY, NEW ZEALAND, AUCKLAND, 0752
出版商Dove Medical Press Ltd.
涉及的研究方向CHEMISTRY, MEDICINAL-PHARMACOLOGY & PHARMACY
出版国家或地区ENGLAND
出版语言English
出版周期
出版年份2007
年文章数 286点击查看年文章数趋势图
Gold OA文章占比96.89%
研究类文章占比:
文章 ÷(文章 + 综述)
77.97%
WOS期刊SCI分区
2022-2023年最新版
WOS分区等级:1区

按学科分区JIF分区JIF排名JIF百分位
学科:CHEMISTRY, MEDICINAL
类别:SCIE
Q219/60
学科:PHARMACOLOGY & PHARMACY
类别:SCIE
Q166/277
中科院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中科院SCI期刊分区
2023年12月最新升级版
点击查看中科院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 1区2区1区
CHEMISTRY, MEDICINAL
药物化学
2区3区2区
PHARMACOLOGY & PHARMACY
药学
4区1区2区
中科院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 1区3区1区
CHEMISTRY, MEDICINAL
药物化学
3区3区2区
PHARMACOLOGY & PHARMACY
药学
1区1区3区
中科院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 1区3区3区
CHEMISTRY, MEDICINAL
药物化学
4区3区3区
PHARMACOLOGY & PHARMACY
药学
2区2区3区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
Directory of Open Access Journals (DOAJ)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1177-8881%5BISSN%5D
平均审稿速度网友分享经验:
>12周,或约稿
平均录用比例网友分享经验:
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在Drug Design Development and Therapy顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 Drug Design Development and Therapy期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Drug Design Development and Therapy中科院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Drug Design Development and Therapy上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中科院SCI期刊分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发表论文
  • 中科院SCI期刊分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    International Journal of Nanomedicine10014.00
    Drug Delivery and Translational Research279.80
    Chinese Medicine346.90
    Chinese Journal of Natural Medicines276.80
    Journal of Global Antimicrobial Resistance167.10
    Expert Review of Neurotherapeutics637.10
    International Journal for Parasitology-Drugs and Drug Resistance277.50
    PEDIATRIC DRUGS556.40
    Clinical Psychopharmacology and Neuroscience224.30
    Australian Prescriber213.30
    中科院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE606039
    BIOMATERIALS517042
    BIOMEDICINE & PHARMACOTHERAPY469000
    Journal of Materials Chemistry B462423
    Frontiers in Pharmacology453800
    Frontiers in Immunology425455
    JOURNAL OF ETHNOPHARMACOLOGY408894
    COLLOIDS AND SURFACES B-BIOINTERFACES406182
    Frontiers in Oncology386986
    Acta Biomaterialia378619
  •  

    Drug Design Development and Therapy Drug Design Development and Therapy
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Binary Nanodrug-Delivery System Designed for Leukemia Therapy: Aptamer- and Transferrin-Codecorated Daunorubicin- and Luteolin-Coloaded Nanoparticles

    Author: Zhu, Yuanyuan; Zhang, Wei; Chen, Jing
    Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2023; Vol. 17, Issue , pp. 1-13. DOI: 10.2147/DDDT.S387246
        PubMed      DOI
    2.Menthone Exerts its Antimicrobial Activity Against Methicillin Resistant Staphylococcus aureus by Affecting Cell Membrane Properties and Lipid Profile

    Author: Zhao, Wenming; Yang, Chengwei; Zhang, Ning; Peng, Yuanyuan; Ma, Ying; Gu, Keru; Liu, Xia; Liu, Xiaohui; Liu, Xijian; Liu, Yumin; Li, Songkai; Zhao, Linjing
    Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2023; Vol. 17, Issue , pp. 219-236. DOI: 10.2147/DDDT.S384716
        PubMed      DOI
    3.Evaluation of Chitosan-Oleuropein Nanoparticles on the Durability of Dentin Bonding

    Author: Zhao, Shuya; Zhang, Yunyang; Chen, Yun; Xing, Xianghui; Wang, Yu; Wu, Guofeng
    Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2023; Vol. 17, Issue , pp. 167-180. DOI: 10.2147/DDDT.S390039
        PubMed      DOI
    4.Efficacy and Mechanism of Qianshan Huoxue Gao in Acute Coronary Syndrome via Regulation of Intestinal Flora and Metabolites

    Author: Zhao, Ning; Ma, Yan; Liang, Xiaoxue; Zhang, Yu; Hong, Dacheng; Wang, Ying; Bai, Dong
    Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2023; Vol. 17, Issue , pp. 579-595. DOI: 10.2147/DDDT.S396649
        PubMed      DOI
    5.Network Pharmacology and Experimental Validation to Explore the Effect and Mechanism of Kanglaite Injection Against Triple-Negative Breast Cancer

    Author: Zhao, Mei; Fu, Lijuan; Xu, Panling; Wang, Ting; Li, Ping
    Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2023; Vol. 17, Issue , pp. 901-917. DOI: 10.2147/DDDT.S397969
        PubMed      DOI
    6.Network Pharmacology and Experimental Validation to Explore That Celastrol Targeting PTEN is the Potential Mechanism of Tripterygium wilfordii (L?v.) Hutch Against IgA Nephropathy

    Author: Zhao, Juanyong; Liu, Haiyang; Xia, Ming; Chen, Qian; Wan, Lili; Leng, Bin; Tang, Chengyuan; Chen, Guochun; Liu, Yu; Zhang, Lei; Liu, Hong
    Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2023; Vol. 17, Issue , pp. 887-900. DOI: 10.2147/DDDT.S402503
        PubMed      DOI
    7.Shensong Yangxin Capsule Reduces the Susceptibility of Arrhythmia in db/db Mice via Inhibiting the Inflammatory Response Induced by Endothelium Dysfunction

    Author: Zhang, Jiehan; Li, Hongrong; Wang, Dandong; Gu, Jiaojiao; Hou, Yunlong; Wu, Yiling
    Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2023; Vol. 17, Issue , pp. 313-330. DOI: 10.2147/DDDT.S392328
        PubMed      DOI
    8.Review on the Diverse Biological Effects of Glabridin

    Author: Zhang, Jianhong; Wu, Xinhui; Zhong, Baiyin; Liao, Qicheng; Wang, Xin; Xie, Yuankang; He, Xiao
    Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2023; Vol. 17, Issue , pp. 15-37. DOI: 10.2147/DDDT.S385981
        PubMed      DOI
    9.Andrographolide Inhibits Static Mechanical Pressure-Induced Intervertebral Disc Degeneration via the MAPK/Nrf2/HO-1 Pathway

    Author: Zhang, Cunxin; Lu, Ziang; Lyu, Chaoliang; Zhang, Shanshan; Wang, Dechun
    Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2023; Vol. 17, Issue , pp. 535-550. DOI: 10.2147/DDDT.S392535
        PubMed      DOI
    10.The Underling Mechanisms Exploration of Rubia cordifolia L. Extract Against Rheumatoid Arthritis by Integrating Network Pharmacology and Metabolomics

    Author: Zeng, Weiya; Fang, Yuan; Mo, Suifen; Shen, Caihong; Yang, Huiling; Luo, Guihua; Xiao, Luhua; Zhan, Ruoting; Yan, Ping
    Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2023; Vol. 17, Issue , pp. 439-457. DOI: 10.2147/DDDT.S388932
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE MEDICINE497107.50
    Nature Reviews Disease Primers4860.90
    同分区等级的其他期刊名称 h-index CiteScore
    Living Reviews in Relativity065.50
    Living Reviews in Relativity7565.50
    JOURNAL OF TRAVEL MEDICINE5119.60
    Military Medical Research030.10
    Advanced Composites and Hybrid Materials016.90
    INTERNATIONAL JOURNAL OF COMPUTER VISION17222.50
    Eurosurveillance9027.70
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE715.70
    Small Structures00.00
    Trends in Chemistry032.10


以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

    同领域作者分享投稿经验:共389条 (包含回复)

我来分享

    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海分公司    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960

    增值电信业务经营许可证:沪B2-20211595

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室

    United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451